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Abstract
When investigating the mode of hydrogen activation by [Fe] hydro-
genases, not only the chemical reactivity at the active site is of impor-
tance but also the large-scale conformational change between the so-called
open and closed conformations, which leads to a special spatial arrange-
ment of substrate and iron cofactor. To study H2 activation, a complete
model of the solvated and cofactor-bound enzyme in complex with the
substrate methenyl-H4MPT
+ was constructed. Both the closed and open
conformations were simulated with classical molecular dynamics on the
100 ns time scale. Quantum-mechanics/molecular-mechanics calculations
on snapshots then revealed the features of the active site that enable
the facile H2 cleavage. The hydroxyl group of the pyridinol ligand can
easily be deprotonated. With the deprotonated hydroxyl group and the
structural arrangement in the closed conformation, H2 coordinated to the
Fe center is subject to an ionic and orbital push–pull effect and can be
rapidly cleaved with a concerted hydride transfer to methenyl-H4MPT
+.
An intermediary hydride species is not formed.
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1 Introduction
[Fe] hydrogenase1–5 , which features a mononuclear iron complex in the ac-
tive site, differs in the mode of action compared to [NiFe] and [FeFe] hydroge-
nases.6–10 In [FeFe] and [NiFe] hydrogenases, direct H2 cleavage or formation is
a redox process accomplished by oxidation state changes of the active Fe and
Ni atoms, respectively.6–10 The reaction catalyzed by [Fe] hydrogenase,
methenyl − H4MPT+ + H2  methylene − H4MPT + H+,
is fundamentally different. No oxidation-state change of the active iron could be
detected experimentally.11–14 [Fe] hydrogenase requires the substrate methenyl-
H4MPT
+ (see Fig. 1), which acts as the hydride acceptor. The question is
therefore why the iron cofactor iron-guanylylpyridinol (FeGP) (Fig. 1) is re-
quired for catalysis11,15 even though it does not seem to be redox-active.
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Figure 1: Top: Lewis structure of the FeGP cofactor. Bottom: Lewis structure
of methylene-H4MPT. The parts of methylene-H4MPT are denoted according to
their chemical building blocks, following Ref. 16. Both molecules are depicted
as parametrized for molecular-dynamics simulations (the cysteinate ligand is
modeled by a methylthiolate).
An accurate mechanistic description of the H2 activation process must thus
be able to account for the intriguing role of the metal cofactor. Yang and Hall
were the first to investigate the mechanism computationally, using a truncated
active-site model in an electrostatic continuum.17 The first main step of the cat-
alytic cycle is the heterolytic H2 cleavage, with the proton transferred to either
the oxypyridine ligand (deprotonated pyridinol) or the cysteinate ligand, which
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need to be present in the deprotonated form. The second main step is hydride
transfer to methenyl-H4MPT
+,17 which is the rate-limiting step.17 However, the
theoretical description with density-functional-theory (DFT) methods is sensi-
tive to the incorporation of empirical dispersion corrections and the energetics
of all elementary reaction steps can be manipulated by first-shell ligand modifi-
cations.18 Yang and Hall formulated the product of H2 cleavage as a bound
dihydrogen species with an elongated, polarized H–H bond, Fe(II)· · ·Hδ−—
Hδ+ · · ·−O. This species is the resting state in their catalytic cycle.17 This
intermediate could, however, also be described as a hydride complex.18,19
The difficulties fully to reconcile the experimental observations with that
mechanism, which was derived based on a small model, point to the need for
an extended theoretical treatment of the reaction. Any mechanistic propos-
als should be compatible with the following experimental data: (i) If the key
intermediate was a stable hydride species, the electronic structure of the Fe
atom would change. However, experimental and theoretical Mo¨ssbauer spectra
indicate that no stable hydride or H2-bound species exists under turnover condi-
tions.12,19,20 (ii) Model compounds that accurately mimic the first coordination
sphere of the iron do not even bind H2,
21–23 hence, the protein environment is
likely to be crucial. (iii) In model compounds, protonating the thiolate ligand
leads to dissociation of the ligand.24 This indicates that also in the enzyme,
the thiolate might not be a viable proton acceptor. (iv) Mutating histidine 14
to alanine reduces the catalytic activity to 1 % of the wild-type level.16,25 The
mechanism should thus explain why His14 is important for the catalytic activity.
Already in 2009, Hiromoto et al. suggested that a large-scale protein motion
might play a role in catalysis.16 The dimeric protein has three subunits (see
Fig. 2): The central subunit, which is formed from the intertwined C-terminal
domains of both monomers, and two identical peripheral subunits.26 The pe-
ripheral subunits each harbor an FeGP cofactor;25 methenyl-H4MPT
+ binds to
the central subunit.16 The protein can adopt two conformational states, referred
to as open and closed, respectively. In the open conformation, there is a cleft
between the central and the peripheral subunits, as shown in Fig. 2.25,27
Hiromoto et al. proposed a mechanism where binding of methenyl-H4MPT
+
to the open enzyme induces the transition to the closed conformation, in which
methenyl-H4MPT
+ and FeGP are arranged such that H2 binding and cleavage
can occur and methenyl-H4MPT
+ is reduced to methylene-H4MPT. Thus, the
closed enzyme is the reactive conformation. Transition back to the open confor-
mation and dissociation of the product methylene-H4MPT closes the catalytic
cycle. Hiromoto et al. further postulated that the geometrical arrangement of
FeGP and methenyl-H4MPT
+ imposed by the protein in the closed conforma-
tion is necessary for catalysis to occur.
To model the reaction accurately, a method is required that incorporates
the geometrical constraints imposed by the protein and, if possible, also the
electronic polarization exerted by the environment. Combined quantum me-
chanics/molecular mechanics (QM/MM) fulfils both these requirements.28,29 A
further complication is that a crystal structure of the closed conformation is only
available for the apoenzyme,26 while the holoenzyme could only be crystallized
3
FeGPmethylene-H4MPT
central hinge peripheralhingeperipheral
monomer 1monomer 2
Figure 2: Cartoon structure of our model of the substrate- and cofactor-bound
protein dimer in the open conformation (top) and in the closed conformation
(bottom). The red arrows point to the Fe-center and the hydride-accepting
carbon atom of the substrate.
in the open conformation.25,27 A crystal structure of the enzyme in complex with
the substrate is available only for the C176A mutant in the open conformation.
Thus, suitable starting structures for the wild-type holoenzyme–substrate com-
plex in the open and closed conformations must be devised first.
To investigate the crucial H2 cleavage step, we generated such starting struc-
tures of the enzyme–substrate complex in the open and closed conformations.
In the subsequent molecular-dynamics (MD) simulations, the FeGP cofactor
and methylene-H4MPT (compare Fig. 1) were parametrized with the General
Amber Force Field (GAFF).30 We chose to simulate the enzyme–product com-
plex because methylene-H4MPT is more straightforward to parameterize with
GAFF than methenyl-H4MPT
+. According to the principle of microscopic re-
versibility,31 this corresponds to the product structure directly after hydride
transfer, and the sampled configurations are relevant for both reaction direc-
tions. The Fe atom, both CO ligands, the cysteinate S atom, the acyl CO of
the pyridinol ligand, and the oxygen atom of the bound water were position-
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ally restrained to avoid the need for Fe–L bonded parameters. As FeGP is
strongly bound to the peripheral subunit, these restraints effectively lock the
hinge motion that would interconvert open and closed conformations. However,
this conformational change is likely to take place on a time scale much longer
than the sampling times used here. The protein was described with the Amber
ff03 force field.32,33 MD simulations were run with Gromacs 4.5.534–37 (open
conformation: 100 ns, closed conformation: 95 ns). Starting from snapshots
of the MD trajectory, the H2 splitting reaction was investigated by QM/MM
calculations. These were performed with ChemShell38–40 interfaced to Tur-
bomole41,42 as QM back-end. QM calculations used the TPSS-D343,44 DFT
method with the def2-TZVP45 basis set for iron and the def2-SVP46 basis set
on all other atoms. The effect of a larger basis set was assessed for one reaction
step and the differences in energies and structures were found to be negligible.
The TPSS exchange-correlation functional is computationally efficient and reli-
able47 and has already been applied in earlier studies of [Fe] hydrogenase.17,18
Because of the many non-covalent contacts of methylene-H4MPT and FeGP,
the use of dispersion corrections significantly affects the hydride transfer step in
smaller models,18 which is the reason for applying the Grimme ’D3’ correction
here as well.44 Details on model construction and computational methods can
be found in the electronic supporting information (ESI).
Herein, we use a full model of the dimeric enzyme in molecular-dynamics
simulations and QM/MM calculations to address two central questions relating
to the H2-activation mechanism in [Fe] hydrogenase. These are the protonation
state of the FeGP cofactor and the possible H2-activation pathways in the closed
conformation.
2 Molecular dynamics simulations
2.1 Open conformation
The MD simulations of the dimer with both monomers in the open conformation
yield insights into the dynamics around the cofactor in this non-reactive confor-
mation. The methylene-H4MPT molecules (one bound to each monomer) stay
attached to the central subunit of the protein throughout the simulation, mainly
due to hydrogen-bonding interactions. Most of these interactions were already
identified in the crystal structure16 and remained largely stable throughout the
MD trajectory. Important hydrogen bonds are formed between the 2a-amino
group of the pterin unit (see Fig. 3) to the backbone carbonyls of Thr317 and
Cys250. The carbonyl group of Cys250 also forms a hydrogen bond with the
pterin N3–H. The hydroxyl of Ser320 occasionally forms a hydrogen bond to
the pterin 2a-amino group and the carbonyl of Ser320 with the pterin N8–H.
The hydroxyl group of Ser254 occasionally also engages in a hydrogen bond
to the pterin 2a-amino group. The tail of methylene-H4MPT is highly flexible
and mainly involved in hydrogen bonds to surrounding water molecules. One
relatively stable hydrogen bond is formed between Lys151 and either of the glu-
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tarate carboxylates (but also to the phosphate). The tail can adopt an extended
conformation, and occasionally the glutarate carboxylates form hydrogen bonds
with the distant residues Asn153, Lys154, Lys182 or Lys131. However, the pre-
dominant conformation of the tail is U-shaped, with the bend at the ribose.
Snapshots from the MD simulations with methylene-H4MPT in either confor-
mation are shown in Fig. 3.
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Thr317Ser320
Ser254
Figure 3: Representative snapshots of methylene-H4MPT in the U-shaped con-
formation (left) and in an extended conformation (right).
The different conformational behavior of the head and tail parts of bound
methylene-H4MPT are mirrored in the RMSD (root-mean-square deviation)
with respect to the starting structure. The evolution of the RMSDs of the head
and tail parts of both independent methylene-H4MPT molecules over the whole
trajectory are plotted in Fig. 4. The RMSD of the head fluctuates between 1
to 2 A˚, so this part of the molecule remains essentially fixed. In contrast, the
RMSD of the conformationally flexible, very mobile tail is around 5 A˚ (U-shaped
tail), with values up to 10 A˚ corresponding to the extended conformation.
In the open conformation, the Fe center is exposed to the solvent. The
hydroxyl group of the pyridinol ligand mainly hydrogen-bonds to the water
molecule coordinated to Fe (whose oxygen atom was positionally restrained). It
can also form hydrogen bonds to bulk water molecules. Interestingly, there is a
relatively abundant conformation where the hydroxyl group forms a hydrogen
bond to His14. His14 is known to be crucial for high catalytic rates, since a
H14A mutation reduces the turnover rate to 1 % of the wild-type level.25 The
presence of this hydrogen-bonded conformation suggests that His14 may act as
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Figure 4: RMSD evolution of the head and tail parts of methylene-H4MPT
bound to monomer 1 (left panel) and monomer 2 (right panel) during the simu-
lation of the open conformation. To calculate the RMSD, one frame was selected
every 40 ps and the protein backbone atoms of every structure were aligned.
a base to deprotonate the pyridinol ligand, as previously suggested.16,25 The
distance between the hydroxyl proton and N of His14 for both monomers is
plotted in Fig. 5. In monomer 1, this hydrogen bond is formed frequently at
the beginning of the trajectory but is no longer present beyond 36 ns, whereas
in monomer 2, it was mainly observed later during the simulation (see Fig. 5).
Figure 5: Distance between the proton of the pyridinol OH group and N of
His14 for both monomers during the MD simulation of the open conformation.
2.2 Closed conformation
The simulation of the closed conformation samples the conformations of the
protein in the state that is believed to be reactive.16 The reduced substrate
methylene-H4MPT is bound in the active-site cleft with the hydride-accepting
C14a atom in spatial proximity to the Fe atom of FeGP. The geometrical ar-
rangement of methylene-H4MPT and the iron center is stable throughout the
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simulation. The mean distance between Fe and C14a increased from approxi-
mately 3.8 A˚ (0 to 30 ns) to around 4.3 A˚ (30 to 90ns) in monomer 1, while it re-
mained constant at approximately 4.3 A˚ throughout the simulation of monomer
2. Notably, methylene-H4MPT blocks a water channel identified in the crystal
structure.16 However, a few water molecules are still able to enter the active
site by passing along the cofactor already during the first few nanoseconds of
the MD simulation. This fast access of a few water molecules indicates that
water is able to enter the active-site region through the cavity in the closed
conformation.
The hydrogen bond between the pyridinol hydroxyl and His14, already ob-
served in the open conformation, is formed in the closed conformation as well.
The distance between the hydroxyl proton and N of His14 for both monomers
is plotted in Fig. 6. In monomer 2, this hydrogen bond (OH–N distance of
Figure 6: Top panels: Distance between the proton of the pyridinol OH group
and N of His14 for both monomers during the MD simulation of the closed
conformation. Bottom panels: Representative snapshots of the three hydrogen-
bonding modes (direct hydrogen bond, one bridging water, no hydrogen bond).
about 2 A˚) is frequently formed and broken over the course of the simulation.
In monomer 1, the OH–N distance plot shows three stages (see Fig. 6). In
the first phase, up to 30 ns, a direct hydrogen bond is often formed. From 30
to 51 ns, the OH–N distance remains at around 4.5 A˚. In this phase, a water
molecule that entered the active site bridges the hydroxyl group and N (OH–
HOH–N). Thus, water-mediated proton transfer should still be possible. In
the third phase, from 51 to 88 ns, the hydrogen bond is lost and re-forms again
only after 88 ns with one bridging water molecule. Hence, in both monomers,
deprotonation of the pyridinol with His14 as the base should be viable. The
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proton transfer may be mediated by a water molecule bridging between the
hydroxyl and the proton-accepting N.
3 QM/MM calculations
3.1 Protonation state of the guanylylpyridinol ligand
methylene-H4MPT
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Figure 7: Left: Lewis representation of the active site of [Fe] hydrogenase with
the reduced substrate methylene-H4MPT. The QM region utilized to model
hydrogen splitting is marked in red. Right: Lewis representation of the active
site including His14. The QM region chosen to model the proton transfer from
pyridinol to His14 (labeling according to PDB code 3H6516) is marked in green.
The bound water molecule (green) is only present in the open conformation.
Hydrogen atoms involved in the reactions are printed blue.
To investigate possible H2 activation mechanisms, we first need to clarify
the protonation state of the active site. The experimentally verified importance
of His14 for a high turnover rate16,25 and the hydrogen bond between His14
and the pyridinol OH observed in the MD simulations point to a crucial role
of His14 as the base in the proton transfer pathway. Deprotonation of the hy-
droxyl group results in a potent proton acceptor (oxypyridine) for heterolytic
H2 cleavage. To investigate the energetics of pyridinol deprotonation, we chose
two representative MD snapshots that feature the OH–His14 hydrogen bond:
One snapshot from the open conformation (at 10.78 ns) and one from the closed
conformation (at 13.2 ns). Both snapshots were prepared for QM/MM optimiza-
tion, i.e., the full protein plus a water shell around one of the active sites was
extracted (see ESI for details). The QM region contained the FeGP cofactor up
to the phosphate linker (with an Fe-bound water in the open conformation) and
the His14 side chain; see Fig. 7. The optimized structures of the pyridinol/His
and oxypridine/HisH+ forms are presented in Fig. 8.
In the closed conformation, the proton transfer is endothermic by +2.3 kcal/mol.
From a potential-energy surface (PES) scan along the proton-transfer coordinate
(defined as the difference between O–H and H–N bond lengths), we estimate
9
Figure 8: QM/MM-optimized reactant (left column) and product (right column)
structures for the proton transfer from pyridinol OH to His14. Top row: closed
conformation; bottom row: open conformation with Fe-bound water. Water
molecules in the active site are shown as “ghost atoms”; selected distances are
given in A˚.
an upper bound for the proton-transfer barrier of +4.6 kcal/mol (+2.3 kcal/mol
for the back reaction). Thus, proton transfer between the pyridinol OH and
His14 is facile, with the OH/His form being favoured. Considering that His14
is connected to the bulk solvent through a proton-transfer chain, we conclude
that the less favoured oxypyridine (O−/HisH+) form is still present in significant
amounts under equilibrium conditions.
In the open conformation, the proton transfer is thermoneutral (∆E =
0.0 kcal/mol). The oxypyridine form is thus equally likely. Although we did
not calculate the reaction barrier for this case, it is reasonable to assume that it
will be similar to the barrier in the closed conformation as the proton transfer
reactions are the same in both cases, except for a slight change in the envi-
ronment. The stabilization of the oxypyridine form in the open conformation
compared to the closed conformation arises because the water molecule coordi-
nated to iron can form a hydrogen bond to the oxypyridine oxygen, stabilizing
the anion. Note that the active site in the open conformation is exposed to
the bulk solvent and thus filled with water (see Fig. 8). For the H2 activation
to proceed, the bound water must be displaced by H2. Based on all available
data, we cannot assess with any certainty if this happens while the enzyme is
in the open or the closed conformation. As we have found that the active site is
still accessible to water in the closed conformation (see Sect. 2.2), it is certainly
possible for H2 to enter the active site only after the closed conformation has
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formed. What is clear, however, is that the prevailing protonation state of the
pyridinol/His14 pair will critically depend on the external pH.
3.2 H2 activation
To investigate hydrogen cleavage and hydride transfer to methenyl-H4MPT
+,
we chose two representative snapshots from the closed conformation: one with a
short Fe–C14a distance of 3.7 A˚ (at 11 ns) and one with a longer distance of 4.3 A˚
(at 56.5 ns). Because the hydride is transferred to C14a of methenyl-H4MPT
+,
one might expect the reaction to be facilitated by a short Fe–C14a distance,
and our discussion thus focuses first on the former snapshot. The QM region
included again FeGP up to the phosphate linker, together with the chemically
relevant part of the substrate and H2 (see Fig. 7). In the selected snapshot,
the pyridinol-OH–His14 hydrogen bond is not present. Note that His14, in
the neutral form, is in the MM region and does not directly participate in the
reaction. Considering that the pyridinol–His14 hydrogen bond is frequently
formed and broken (see Fig. 6) and that the proton transfer is kinetically facile
(see Sect. 3.1), this choice of setup sustains two scenarios: (i) The pyridinol
ligand has been deprotonated via His14, and the proton removed from the active
site through the proton-transfer chain, leaving behind oxypyridine and neutral
His14. (ii) The pyridinol ligand remains neutral, without hydrogen-bonding to
(also neutral) His14.
Figure 9: QM/MM-optimized reactant (left) and product (right) structures of
the H2 cleavage reaction for the scenario with oxypyridine ligand. Distances are
given in A˚.
3.2.1 H2 activation via oxypyridine.
For the scenario with oxypyridine, we studied several possible hydrogen coor-
dination modes to the open coordination site at the Fe center: end-on and two
rotamers of side-on coordination. All initial structures converged to a side-on-
coordinated hydrogen molecule, which is thus the reactant for the hydrogen
cleavage reaction. The structure is shown in Fig. 9. N5 and N10 of the imi-
dazolidine ring are sp2-hybridized and conjugated with C14a, thus stabilizing
the cation. The coordinated H2 is activated, its bond being elongated to 0.83 A˚
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(from 0.74 A˚ in free H2). There is only one reasonable pathway to cleave H2
in this configuration: In a concerted heterolytic cleavage step, the proton is
transferred to the oxypyridine oxygen and the hydride to C14a of methenyl-
H4MPT
+. This reaction is exothermic by −18.7 kcal/mol. A PES scan (along
the difference of O–H and H–H bond lengths) provided an upper bound for the
barrier of about +1.0 kcal/mol. Despite various attempts, we were unable to
locate a stable minimum on the PES that would correspond to an iron hydride
species. Hence, we find that the iron is involved in H2 binding and activation,
but does not bind a hydride species. The H2 cleavage mechanism we have iden-
tified here thus complies with the first of the requirements formulated in Sect.
1.
In the reactant complex, the coordinated H2 is subjected to an electronic
push–pull effect from the negatively charged oxypyridine oxygen and the posi-
tively charged carbocation of methenyl-H4MPT
+. This is reflected in the rel-
evant frontier orbitals (Fig. 10): The LUMO has a strong contribution from
the pz orbital on C14a, which is oriented perpendicular to the ring plane. The
HOMO−2 is delocalized over the oxypyridine ring and the thiolate S atom,
with a strong contribution from the oxypyridine oxygen. (Note that HOMO
and HOMO−1 are strongly localized on the phosphate linker and thus do not
contribute to the reactivity at the iron center).
In the optimized product structure the O–H bond of the pyridinol hydroxyl
points towards the empty coordination site of the iron center (Fig. 9). The
newly formed C14a–H bond is pointing towards the Fe atom. It is slightly
elongated (1.19 A˚ compared to 1.10 A˚ for the other C14a–H bond), indicating a
weak interaction with the iron center. Another conformer, where the O–H bond
has turned away from the iron, was found to be 2.3 kcal/mol more stable.
In both conformers, the imidazolidine ring of methylene-H4MPT is only
slightly puckered. The geometry at N10 is almost planar in both conformers,
indicating sp2 hybridization (∆ = 0.02 A˚ and ∆ = 0.10 A˚, respectively; ∆, as
defined by Dunitz and co-workers,48 measures the degree of pyramidalization
as the distance of the N atom from the plane spanned by its three bonding
partners). N5 is planar in the first conformer (∆ = 0.00 A˚) and only slightly
pyramidalized in the second (∆ = 0.21 A˚). The N5 lone pair in the second
conformer is synclinal to the C–Hpro−R bond. We therefore see no evidence
for a beneficial stereoelectronic effect of the nitrogen lone pairs on C–H bond
formation, which would require a lone pair to be antiperiplanar to the C–Hpro−R
bond.49
Similar results were obtained for the second snapshot, where the substrate
was positioned slightly further away from the iron center (4.3 vs. 3.7 A˚). The
cleavage reaction in that case is even more exothermic (by −26.3 kcal/mol, com-
pared to −18.7 kcal/mol for the first snapshot), and again no iron hydride species
could be optimized. In the product structure, imidazolidine N5 is sp3-hybridized
(∆ = 0.46 A˚, lone pair synclinal to C–Hpro−R) while N10 remains again sp2
(∆ = 0.05 A˚) hybridized. We thus find that fluctuations of the substrate po-
sition of the order as they were observed in the MD simulations have only a
minor effect on the reactivity of [Fe] hydrogenase in the H2 cleavage step.
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Figure 10: HOMO−2 (right) and LUMO (left) of the H2 adduct of the oxypyri-
dine form of the FeGP cofactor.
3.2.2 H2 activation via thiolate.
In the second scenario, we consider the cleavage reaction with a neutral pyridi-
nol ligand. There are two relevant reactant conformers, which differ in the
orientation of the pyridinol O–H bond (Fig. 11). In the following, we quote
energies relative to the favoured conformer with the O–H pointing away from
the iron. The second conformer, where the O–H is pointing towards the co-
ordinated H2, is 5.7 kcal/mol less stable. Direct H2 splitting in the favoured
conformer, with the pyridinol OH acting as the proton acceptor, is not possible:
Product-like starting structures, with one hydrogen atom already transferred to
C14a of methenyl-H4MPT
+, are not stable minima but converged back to re-
actant structures during optimization. For the second conformer, this pathway
is precluded in the first place by the orientation of the pyridinol OH bond.
However, we find for both reactant conformers that hydrogen cleavage can
occur with the thiolate ligand, rather pyridinol OH, as the proton acceptor.
When the OH group is oriented away from the Fe center, the resulting iron hy-
dride structure is not stable but the hydride is directly transferred to methenyl-
H4MPT
+ to form the product. This reaction is exothermic by −4.4 kcal/mol,
significantly less so than hydride cleavage to oxypyridine-O−. For the reactant
conformer with the OH bond oriented towards the Fe center, a stable iron hy-
dride intermediate could indeed be located (Fig. 11). It is only +0.3 kcal/mol
higher in energy than the favoured reactant conformer. The hydride Fe–H bond
length is 1.61 A˚, in excellent agreement with Fe–H bonds in comparable hy-
dride complexes optimized in vacuo19 (1.60 A˚). OH rotation, which is likely to
have a low activation barrier, triggers the transfer of the hydride from iron to
methenyl-H4MPT
+, yielding the same product as direct H2 splitting from the
preferred conformer (see Fig. 11). The thiolate is thus able to act as the base,
which may provide an explanation for the 1 % remaining activity of the H14A
mutation.16,25
Remarkably, the Fe–SH bond in the product (2.34 A˚) is even slightly shorter
than the Fe–S− bond in the reactant (2.36 A˚). In the product, the thiol proton
forms a short hydrogen bond (1.37 A˚) to the pterin carbonyl group of methylene-
H4MPT (see Fig. 11), which is a very good hydrogen-bond acceptor because of
its conjugation with the guanidine moiety in the pterin ring. This in turn
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weakens the S–H bond (elongated to 1.51 A˚, compared to 1.39 A˚ in the hydride
intermediate), which may be described as “partial deprotonation” of the thiol.
The formal thiol ligand in the product is similar in character to a thiolate
in terms of its interaction with the metal center. The thiol–pterin hydrogen
bond thus makes the thiolate a better proton acceptor in the H2 splitting step,
stabilizes the thiol product, and also makes the thiol a better ligand, preventing
it from dissociating like in model complexes. The hydrogen bond is enabled by
the exact positioning of the FeGP cofactor and the methenyl-H4MPT
+ substrate
in the active site. As water molecules are still able to access the active site in
the closed conformation (see Sect. 2.2), we can envisage that the excess proton
on the thiol ligand is removed from the active site via water.
Figure 11: Top row: Structures of the H2 adduct for the second scenario with
neutral pyridinol; the pyridinol OH can be oriented away from Fe (top left) or
towards Fe (top right). Bottom row: Products of H2 cleavage, with the proton
transferred to the thiolate; with the hydroxyl oriented away from Fe (bottom
left) and towards Fe (bottom right). Distances are given in A˚; relative energies
with respect to the favoured adduct are indicated in red in kcal/mol .
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4 Discussion and Conclusions
[FeFe] and [NiFe] hydrogenases cleave or form H2 by redox chemistry;
7–9 a
basic group close to the active iron atom in [FeFe] hydrogenases is important
to donate or accept protons. The mechanism of hydrogen activation in [Fe]
hydrogenase is different. The enzyme has two large-scale conformations, which
differ in the relative orientation of the central and peripheral subunits. In the
closed conformation, the mononuclear iron cofactor (FeGP) and the substrate
are kept in close proximity in an arrangement that is stable over longer time
scales, as we have shown by MD simulations. Our QM/MM calculations have
demonstrated that the pyridinol hydroxyl group can easily be deprotonated via
His14 to form the oxypyridine ligand. The pyridinol ligand in [Fe] hydrogenase
thus has a function similar to the bridgehead amine group of the H-cluster in
[FeFe] hydrogenases.50 However, the oxypyridine plays an additional, crucial
role in activating H2: It is close to the iron atom and represents an ideal Lewis
base. On the other side of the iron is the carbocationic C14a of the substrate
methenyl-H4MPT
+, which is an ideal Lewis acid. Furthermore, both groups
are ionic. When a hydrogen molecule coordinates to the iron, it is polarized
by these charges and subjected to an electronic push–pull effect exerted by the
Lewis pair. The spatial arrangement in the closed conformation is exactly such
that the coordinated H2 lies in-between C14a
+ and O−. This leads to facile,
exothermic heterolytic H2 cleavage, without involving electron transfers to/from
the metal center. The role of oxypyridine as a Lewis base was also proposed to
be relevant for the inhibition by isocyanides.51 The Lewis acid C14a+ is only
present in proximity to FeGP when methenyl-H4MPT
+ is bound in the closed
conformation. H2 cleavage in the open conformation is thus unlikely.
It should be noted that our findings are based on only one or two snapshots
for each scenario. However, as the barriers are very low, it is unlikely that
the consideration of additional snapshots would lead to qualitatively different
conclusions. Furthermore, we considered the proton transfer from pyridinol to
His14 and H2 cleavage (with neutral His14) as separate steps. Other scenarios
are conceivable, for instance, with His14 remaining protonated during H2 cleav-
age or a proton transfer from pyridinol to His14 concerted with H2 cleavage
(direct His14 involvement). The facile pyridinol deprotonation reaction sug-
gests that such a direct involvement of His14 in the H2 cleavage step (general
base effect) might be possible.
The activation mechanism we have described is reminiscent of hydrogen
activation by frustrated Lewis pairs.52 The hydrogen-bound adduct does not
need to be very stable since the H2 cleavage barrier is extremely low (about
1 kcal/mol). Hence, any H2 binding event can directly lead to H2 cleavage,
without requiring a long-lived H2-bound intermediate.
When the pyridinol ligand is not deprotonated, it is still possible to split H2
via proton transfer to the thiolate ligand. However, we have found this pathway
to be much less favorable. This is consistent with observations in biomimetic
model complexes that thiol is a poor ligand.24 The pyridinol/oxypyridine equi-
librium must be strongly affected by the pH, so we would expect the reactivity
15
to depend critically on pH as well, which is indeed the case.1,53
The overall rate of the enzyme depends on additional factors. For the hy-
drogen activation mechanism, the reactive closed conformation must be formed,
which requires large-scale protein motions. Since the reaction barriers in the
closed conformation are very small, we can only speculate that the change in
free energy from open to closed conformation and the associated free-energy
barrier might be rate-limiting for the overall enzymes activity.
The atomistic mechanism of H2 activation in [Fe] hydrogenase we have pro-
posed herein satisfies the criteria set out in Sect. 1: No stable hydride intermedi-
ate; no occurrence of, or requirement for, a long-lived H2 adduct; no involvement
of the thiolate ligand as a proton acceptor; a crucial role for His14. In our pre-
ferred mechanism, the pyridinol hydroxyl group and His14, together with the
stable placement of the substrate carbocation in the active site, are the essential
players, which is in accord with the observation that the enzyme loses 99 % of
its activity upon H14A mutation.25 The residual activity of the H14A mutant
can be explained by the alternative, less favorable activation pathway via the
thiolate.
In the open conformation, which might be prevailing in solution, the water-
bound FeGP cofactor is the most probable form, which agrees with the results
of a theoretical Mo¨ssbauer study.19
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1
1 Computational details
1.1 Parametrization of methylene-tetrahydromethanopte-
rin and iron-guanylylpyridinol
To be able to study [Fe] hydrogenase by means of molecular-dynamics (MD)
simulations and quantum-mechanics/molecular-mechanics (QM/MM) calcula-
tions a force-field description of the whole system is necessary. We chose the
Amber force field (version ff031,2) for the molecular-mechanics (MM) part. This
force field can be combined with the general Amber force field (GAFF),3 which
allows for an easy parametrization of organic molecules. We followed the GAFF
parametrization procedure to derive parameters for the iron-guanylylpyridinol
(FeGP) (see Fig. 1 in the main paper) cofactor and the substrate methylene-te-
trahydromethanopterin (methylene-H4MPT, see Fig. 1 in the main paper). The
parametrization can be divided into two steps. As first step, partial charges de-
rived from the electrostatic potential (ESP) for all atoms were calculated. Then,
GAFF topology files for the organic parts were created. The parameters used
are given in Figs. 1, 2 and Tables 1, 2.
1.1.1 Calculation of partial charges
For the calculation of partial charges, we chose a procedure similar to that ap-
plied in Ref. 1. Structures were optimized with the Gaussian09 program pack-
age,4 utilizing density functional theory with the B3LYP exchange-correlation
functional,5–7 a 6-31+G∗ basis set8,9 and the integral equation formalism polar-
izable continuum model (IEFPCM)10,11 with  = 4 to account for electrostatic
screening. Note that in Ref. 1 structures were optimized with the Hartree–Fock
method. Partial charges were calculated with the Turbomole program pack-
age (version 6.3.1)12,13 according to a scheme related to that suggested by Koll-
man.14 For the Turbomole calculations, density functional theory with the
B3LYP exchange-correlation functional,5–7 the conductor-like screening model
( = 4)15 and an aug-cc-pVTZ basis set16–18 on all atoms was employed.
Unconstrained structure optimization of methenyl-H4MPT (starting struc-
ture from PDB file 3H6519) leads to the formation of internal hydrogen bonds
of the tailing carboxylate groups to hydroxo groups of either the furanose ring
or the glycerin-derived part. These internal hydrogen bonds are not found in
the protein structure because the carboxylates can form intermolecular hydro-
gen bonds. Hence, intramolecular hydrogen bonds do not resemble the bonding
situation in the crystal structure and need to be avoided. This was achieved by
constraining several dihedral angles during optimization.
1.1.2 Generation of GAFF topologies
The generation of GAFF topologies for methylene-H4MPT was straightforward.
Topology files were created with the program ACPYPE,20 which interfaces An-
techamber21 of AmberTools 1322 to create Amber and Gromacs topology
files. The whole methylene-H4MPT molecule was treated as one MM-residue.
Generation of suitable parameters for the FeGP cofactor was more involved.23
Since metal complexes are not parametrizable with GAFF the cofactor was split
up into the guanylylpyridinol ligand, 2 CO molecules, the iron ion (each treated
2
as one MM-residue) and the cysteine rest. For the iron ion a new ion type was
introduced. The two CO molecules were parametrized with GAFF. The guany-
lylpyridinol ligand could be parametrized with GAFF, however, the parameters
of the acyl part coordinating the iron atom had to be adjusted (equilibrium
value of the acyl O–C–C angle) (see Fig. 1 in the main paper for the struc-
ture). In the crystal structure, the open coordination site is coordinated by
water. For this water molecule, the standard parameters of the TIP3P water
model24 were used as the ESP-calculated partial charges differed insignificantly
from the standard charges. For the cysteinate rest, a modified cysteinate residue
was defined, which had the same bonded and van der Waals parameters as a
standard cysteinate, but ESP-derived charges. With a view on terminating the
QM region at the cysteinate Cβ–Cα bond in the subsequent QM/MM calcula-
tions, while maintaining integer charges for the QM and MM regions, a charge
of +0.069588e was distributed equally among the CβH2 atoms of the new cys-
teinate residue to obtain a total integer charge of −1e for FeGP. Since the Fe
atom, both CO molecules, the cysteine sulfur atom, and the CO atoms of the
acyl-ligand were positionally restrained during the classical MD simulations, no
metal–ligand bonded parameters had to be derived.
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Figure 1: Atom types and atom numbers for the FeGP cofactor. GAFF atom
types are given in red, atom numbers in blue. Pink numbers indicate the first
and the second CO ligand.
1.2 Preparation of the protein structures for MD simula-
tions
1.2.1 Open conformation
The simulations are based on the crystal structure published by Hiromoto et
al.19 (PDB code: 3H65). They achieved to crystallize a C176A mutant that har-
bors the cofactor, ligated by dithiothreitol (buffer molecule) instead of Cys176,
in complex with the substrate methylene-H4MPT. The crystal structure is in the
open conformation. In the crystal structure, the C-terminal residues 346–358
3
Table 1: Atom types and partial charges of the FeGP cofactor for the MD simu-
lations and for the QM/MM calculations. The structure with the corresponding
atom numbers is given in Fig. 1.
atom MD charge QMMM charge atom MD charge QMMM charge
Fe(CO)2SC
βH2
Fe 0.7416375 0.741585 S −0.4603 −0.460350
C1 0.074899 0.074849 Cβ −0.186503 −0.186553
O1 −0.223267 −0.223317 Hβ 0.126296 0.126246
C2 0.143396 0.143346 Hβ 0.126296 0.126246
O2 −0.243743 −0.243793
guanylylpyridinol
1 p5 1.173428 1.173379 30 o −0.638592 −0.638525
2 o −0.804905 −0.804954 31 c3 −0.290532 −0.290582
3 o −0.758151 −0.758200 32 nc −0.659167 −0.659100
4 os −0.248012 −0.248061 33 c1 0.510845 0.510795
5 c3 −0.232453 −0.232502 34 cd 0.214577 0.214644
6 os −0.451749 −0.451798 35 o −0.634698 −0.634748
7 c3 0.336367 0.336435 36 na −0.102300 −0.102233
8 os −0.579760 −0.579692 37 ho 0.456286 0.456236
9 c3 −0.019723 −0.019655 38 hc 0.127078 0.127028
10 oh −0.646053 −0.645985 39 hc 0.164999 0.164949
11 c3 0.161410 0.161478 40 hc 0.168804 0.168754
12 oh −0.687887 −0.687819 41 hc 0.148313 0.148263
13 c3 0.430294 0.430362 42 hc 0.124692 0.124642
14 nb −0.296088 −0.296137 43 hc 0.100120 0.100070
15 n −0.657113 −0.657045 44 hc 0.147854 0.147804
16 ca 0.364888 0.364839 45 hc 0.130894 0.130844
17 cc 0.770287 0.770355 46 h1 0.120443 0.120393
18 nh −0.851084 −0.851016 47 h1 0.172266 0.172216
19 oh −0.601450 −0.601499 48 h1 0.088891 0.088958
20 ca 0.244988 0.244939 49 h1 0.235349 0.235416
21 c3 −0.501514 −0.501563 50 ho 0.408312 0.408379
22 nd −0.690035 −0.689967 51 h1 0.093079 0.093146
23 ca −0.222549 −0.222598 52 ho 0.439216 0.439283
24 cd 0.291468 0.291536 53 h2 0.035636 0.035703
25 ca 0.385152 0.385101 54 hn 0.400592 0.400659
26 cc 0.184629 0.184696 55 hn 0.389254 0.389321
27 c3 −0.432668 −0.432718 56 hn 0.415823 0.415890
28 ca −0.163103 −0.163153 57 h5 0.138101 0.138168
29 c 0.595243 0.595310
H2O
O −0.834000 −0.834000 H 0.417000 0.417000
H 0.417000 0.417000
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Table 2: Atom types and partial charges of methylene-H4MPT for the MD simu-
lations and for the QM/MM calculations. The structure with the corresponding
atom numbers is given in Fig. 2.
atom MD charge QMMM charge atom MD charge QMMM charge
1 nc −0.839624 −0.839569 49 o −0.918099 −0.918141
2 cd 0.866549 0.866604 50 c3 −0.462739 −0.462781
3 nh −0.869435 −0.869380 51 c3 0.054124 0.054082
4 n −0.711463 −0.711408 52 c 0.877807 0.877765
5 c 0.716700 0.716755 53 o −0.876948 −0.876990
6 o −0.679835 −0.679780 54 o −0.944601 −0.944643
7 cd −0.258910 −0.258855 55 h1 0.107622 0.107580
8 nh −0.378333 −0.378278 56 h1 0.049829 0.049787
9 c3 0.049297 0.049352 57 hc 0.025634 0.025592
10 c3 0.358361 0.358415 58 hc 0.086049 0.086007
11 c3 −0.632035 −0.631981 59 hc −0.001997 −0.002039
12 nh −0.584658 −0.584604 60 hc 0.017822 0.017780
13 cc 0.633917 0.633971 61 hc 0.121244 0.121202
14 c3 0.474230 0.474284 62 hc 0.094270 0.094228
15 c3 −0.473377 −0.473323 63 ho 0.417555 0.417513
16 c3 −0.006172 −0.006118 64 ho 0.402850 0.402808
17 nh −0.348532 −0.348478 65 ho 0.364890 0.364848
18 ca 0.224733 0.224787 66 ho 0.434832 0.434790
19 ca −0.327418 −0.327364 67 ho 0.440181 0.440139
20 ca −0.277733 −0.277679 68 hn 0.384391 0.384445
21 ca 0.305265 0.305319 69 hn 0.392875 0.392929
22 ca −0.231917 −0.231863 70 hc 0.088181 0.088235
23 ca −0.320717 −0.320663 71 hc 0.118277 0.118331
24 c3 −0.214567 −0.214610 72 hc 0.129347 0.129401
25 c3 0.490123 0.490080 73 hc 0.152460 0.152514
26 c3 0.131906 0.131863 74 hc 0.165743 0.165797
27 c3 0.268650 0.268607 75 hc 0.170784 0.170838
28 c3 0.007070 0.007027 76 h1 0.075703 0.075661
29 oh −0.639264 −0.639307 77 h1 0.107458 0.107416
30 oh −0.670502 −0.670545 78 h2 0.164069 0.164123
31 oh −0.677646 −0.677689 79 h2 0.045246 0.045300
32 os −0.562346 −0.562389 80 h1 0.070626 0.070584
33 os −0.440433 −0.440475 81 h1 0.013312 0.013270
34 c3 −0.048424 −0.048466 82 h1 −0.018889 −0.018931
35 c3 0.161302 0.161260 83 h1 0.008358 0.008316
36 os −0.512516 −0.512558 84 hn 0.348778 0.348832
37 c3 0.653326 0.653284 85 hn 0.414010 0.414064
38 oh −0.750097 −0.750139 86 h1 −0.062031 −0.061977
39 c3 −0.038881 −0.038923 87 h1 0.039663 0.039717
40 oh −0.748423 −0.748465 88 h1 0.081657 0.081711
41 c3 0.577317 0.577275 89 h1 0.018267 0.018225
42 p5 1.257785 1.257743 90 h1 −0.094589 −0.094631
43 o −0.893733 −0.893775 91 h1 0.095968 0.095926
44 o −0.855874 −0.855916 92 h2 0.054208 0.054166
45 os −0.423072 −0.423114 93 ha 0.180798 0.180852
46 c3 0.299822 0.299780 94 ha 0.146830 0.146884
47 c 0.923333 0.923291 95 ha 0.165934 0.165988
48 o −0.913326 −0.913368 96 ha 0.181818 0.181872
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Figure 2: Atom types and atom numbers of methylene-H4MPT. GAFF atom
types are given in red, atom numbers in blue.
could not be refined. They form an unordered tail, far away from the reactive
centers, and thus were simply omitted. To prepare the structure for the simula-
tions, several modifications had to be made. FeGP is ligated by dithiothreitol in
the crystal structure, which leads to a slight displacement of the whole cofactor
compared to its position in the wild-type structure (without methylene-H4MPT,
PDB code: 3F4725). To obtain a wild-type-like structure Ala176 was mutated
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Table 3: Partial charges of His14 for the QM/MM calculations. Atom names
are according to the Amber ff03.
atom QM/MM charge
N −0.509660
H 0.348160
CA 0.116205
HA 0.134900
CB −0.121078
HB2 0.087889
HB3 0.087889
CG 0.000013
ND1 −0.204225
HD1 0.319833
CE1 0.148833
HE1 0.123742
NE2 −0.599922
CD2 0.045304
HD2 0.111717
C 0.513086
O −0.602692
Table 4: Protonation states of His residues of the modified 3H65 crystal struc-
ture for MD simulations, as determined with the program reduce.27 δ indicates
a proton at Nδ and  indicates a proton at N. pKa values were calculated with
propKa.28
residue H position pKa value
HIS 14 δ 6.57
HIS 41 δ 0.60
HIS 52 δ 5.68
HIS 88 δ 5.24
HIS 120  3.99
HIS 123  5.82
HIS 174 δ 4.08
HIS 201  1.68
HIS 294  5.82
HIS 340 δ 7.22
back to cysteinate and the dithiothreitol ligand was removed from the struc-
ture. To place the cofactor in the correct (wild-type) position, the structure
of the wild type (3F47) was aligned with the structure of the C176A mutant
(3H65) using PyMOL.26 The coordinates of the FeGP moiety (including the
cysteine S atom) in the aligned wild-type structure were then inserted into the
modified mutant structure, replacing those of the misplaced FeGP. With this
procedure, the position of FeGP in the modified mutant structure resembled the
position in the wild-type structure. Only the Cβ–S bond of Cys176 (formerly
Ala176) was stretched from 1.79 A˚ in the wild-type structure to 2.21 A˚ in the
modified mutant structure. The correct bond length is restored in the energy-
minimization step at the start of the MD simulations. The protonation states
of titratable residues were determined with the program reduce,27 which can
also correct flipped Asn/Gln/His residues (none were in this case), and veri-
fied with propKa.28 All titratable residues were in their standard protonation
states; His protonation states are summarized in Table 4. Finally, the whole
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protein dimer was created from the monomer chain with PyMOL.26
1.2.2 Closed conformation
The closed conformation was generated from the modified crystal structure of
the open conformation (see previous section), which we call starting structure
here. The only crystal structure available in the closed conformation is for the
wild-type apoenzyme (PDB code: 2B0J29). To build a model of the complete
enzyme in the closed conformation, the central subunit (residues 253–345) of
2B0J was first aligned to the central subunit of the starting structure. In the
second step, the peripheral subunit (residues 1–241) of the starting structure
was aligned to the peripheral subunit of the now aligned 2B0J. The FeGP co-
factor was aligned together with the peripheral subunit. The structure thus
obtained for the closed conformation of the holoenzyme–substrate complex had
no significant atom overlaps, except for the tail part of methylene-H4MPT (after
the ribitol part, see Fig. 1 of the main paper). This tail was rotated with the
help of the UCSF Chimera program30 to remove atom overlaps. Given the
high flexibility and mobility of the tail, any memory of the initial conformation
will be lost during the MD sampling. In the structure thus generated, there
is a gap in the backbone between residues 241 and 242, between the hinge re-
gion (residues 242–252) and peripheral subunit (see Fig. 3), which will be closed
during energy minimization. Finally, the water molecule coordinated to Fe was
removed because it would prevent the hydride transfer reaction that we intend
to study. With the water molecule absent, the structure is exactly the product
of the hydride transfer. The full dimer was again created with PyMOL.26 A
superposition of the starting structure, the final structure, and the apoenzyme
in the open conformation is presented in Fig. 3. In the generated structure
of the closed conformation, the distance between Fe and the hydride accepting
carbon atom (C14a) is 3.23 A˚, which compares well to the distance of 3 A˚ found
by Hiromoto et al., who modelled the structure of the closed conformation in a
similar fashion.19
1.3 MD simulation protocol
All MD preparation steps and simulations were performed with the Gromacs
molecular dynamics package version 4.5.5.31–34 The protein was centered in a
triclinic box with a minimal distance of 1 nm between solute and box border.
The box was solvated and ions (Na+ and Cl−) were added to neutralize the
system and to obtain an ion concentration of 0.15 mmol/L. The Fe atom, both
CO ligands, the cysteinate S atom, and the CO group of the Fe-coordinating
acyl ligand in the FeGP cofactor were kept frozen or positionally restrained at
their positions in the prepared crystal structure. Positional restraints, rather
than constraints were necessary for the pressure equilibration because pressure
scaling with constrained (frozen) atoms leads to technical difficulties in the
Gromacs implementation.
The integration time step was 2 fs. The linear constraint solver (LINCS)
algorithm to 4th order with 1 iteration was invoked to enforce constraints (all
bonds after energy minimization). Water molecules were kept rigid with the
SETTLE algorithm in all steps after energy minimization. For neighbor search-
ing, a grid-based group cut-off scheme was used with a cut-off distance of 1 nm
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Figure 3: Superposition of the generated closed conformation (cyan), the
apoenzyme in closed conformation (PDB code: 2B0J, yellow) and holoenzyme-
substrate complex in open conformation (PDB code: 3H65, orange). The central
(left side) units are aligned. The peripheral unit of the generated closed con-
formation cyan overlaps with the peripheral unit of the apoenzyme in closed
conformation. The hinge region is marked by a black oval. The black arrows
mark the gap between backbone atoms of residues 241 and 242 (see text).
for short-range interactions and the neighbor list was updated every 10 steps.
Coulomb interactions were calculated with a smooth particle–mesh Ewald algo-
rithm with interpolation order of 4, a Coulomb cut-off of 1 nm, Fourier spacing
of 0.12 nm, tolerance of 10−5 and optimized Fourier transforms. Van der Waals
interactions were calculated with a cut-off scheme (radius = 1 nm). Energy and
pressure were corrected for long-range dispersion effects. Initial velocities were
generated according to a Maxwell–Boltzmann distribution at 293 K. For tem-
perature scaling the system was coupled to a v-rescale thermostat.35 During
equilibration, several subsystems were coupled to their own thermostats. For
production, the entire system was coupled to one thermostat with a relaxation
time of 2 ps and reference temperature of 293 K. Box equilibration was achieved
with isotropic box rescaling by coupling the system to a Berendsen barostat with
1 ps relaxation time, compressibility of 4.5 · 10−5 bar−1, center-of-mass scaling
of reference coordinates, and a target pressure of 1 bar.
The simulation stages are summarized in Table 5. The system in the open
conformation was energy minimized in vacuum and in solvent. During 200 ps
heating in an NV T ensemble, the protein, the cofactor, the substrate and the
solvent were coupled to a temperature bath while all heavy atoms of the pro-
tein were positionally restrained. Thereafter, the box was equilibrated in an
NPT simulation where the restraints on protein atoms were reduced in three
9
steps (total 900 ps). In the first step, protein, cofactor, substrate and solvent
were coupled to three thermostats. In the second and third steps, only two
thermostats were utilized (solvent, rest of the system). After adjustment of the
box vectors (see Table 6), the system was equilibrated in an NV T ensemble for
400 ps with two thermostats (solvent, rest of the system) and finally 2 ns with
one thermostat. The production trajectory was 100 ns. Coordinates were saved
to disk every 20 ps.
The simulation procedure for the closed conformation was similar. Differ-
ences are a reduced force threshold for the vacuum minimization, position re-
straints for the heavy protein atoms during solvent minimization and only two
thermostats (solvent, rest of the system) in all box-equilibration simulations.
The equilibrated box parameters are collected in Table 6. The final equilibra-
tion simulation (NV T ) had to be elongated for an additional 2 ns with a reduced
temperature coupling constant and reduced restraints for Fe and its first-shell
ligands (see Table 6) to avoid instabilities in the production run. Still, the pro-
duction run terminated at 94.6 ns. We trace this back to the initial strain put
into the system during crystal structure manipulation, which could not fully re-
lax because the Fe atoms of the two FeGP cofactors were positionally restrained.
Furthermore, the parameters for FeGP and methylene-H4MPT might be not op-
timal for long simulations. However, the trajectory of 94.6 ns is already longer
than trajectories normally produced to prepare QM/MM calculations36 and is
sufficiently long to allow us to analyse visited conformations, structural behav-
ior, and protein dynamics around the active site. Trajectories were analysed
with the VMD program.37
1.4 QM/MM setup
For the QM/MM calculations, several snasphots representing important confor-
mations were selected, as described in the main paper. As QM/MM calcula-
tions under periodic boundary conditions are not supported by ChemShell,
water molecules and ions outside a shell of 18 A˚ around the quantum-mechanics
(QM) region were therefore discarded to create a finite system. The entire
protein dimer was retained. QM/MM optimizations were carried out with the
ChemShell program38–40 (version 3.5.0) with Turbomole (version 6.5)12,41
as the QM back-end. The optimizations were performed in hybrid delocalized
internal coordinates (HDLCs) using the HDLCOpt module.42 The scaling fac-
tor for Cartesian coordinates when constructing HDLCs was set to 0.8; the
interval to update the pair list and regenerate HDLCs was set to 100 steps; the
convergence threshold was set to 0.001 a.u.
Several regions were defined for the QM/MM optimizations. The QM region
contained all quantum-mechanically described atoms (52 to 84 atoms). The MM
region contained all other atoms of the system (approximately 12350 to 12900
atoms). Only the atoms in the active region (around 670 to 1700 atoms) were
allowed to move in structure optimizations. We used a QM/MM microiterative
optimization scheme 43, in which the inner region (around 61 to 93 atoms)
contained the QM atoms, the MM boundary atoms, and the MM atoms bonded
to the them.
The QM part of the calculations was treated with the TPSS exchange—
correlation functional44–46 plus Grimme’s DFT-D3 dispersion correction.47 Struc-
tures were optimized with the def2-TZVP basis set48 on iron and the def2-SVP
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Table 6: Compositions of the simulation systems
open conformation closed conformation
No. of solute atoms 10852 10846
No. of Na+/Cl− ions 128/96 99/67
No. of water molecules 31800 20889
Initial box size
(a, b/nm, V /nm3) 9.277, 12.273, 1056.34 8.056, 11.390, 739.201
Equilibrated box
(a, b/nm, V /nm3) 9.276, 12.271, 1055.85 8.007, 11.321, 725.755
basis set49 on all other atoms. The resolution of the identity approximation with
corresponding auxiliary basis sets50 was invoked to speed up the calculations.51
The same force-field setup as in the MD simulations was used for the MM re-
gion. QM–MM electrostatic interactions were calculated fully (no cut-off), and
the QM and MM systems were coupled with the charge-shift scheme.39,52–54
Where the QM–MM boundary cut through a covalent bond, the QM region was
saturated with a H link atom. MM partial charges of residues cut by a QM–MM
boundary were corrected such that the QM and MM parts had integer charges.
The correction charge (which is usually of the order of 0.01e) was distributed
equally over the entire residue involved, leading to very minor differences be-
tween the MM and QM/MM partial charges for these residues (see Tables 1, 2,
3).
Two different QM regions were defined (see Fig. 7 of the main paper). The
first QM region contains the Fe center, both CO ligands, the side chain of
the iron-coordinating cysteine (Cys176), the gunaylylpyridinol ligand up to the
phosphate linker and the hydride-acceptor up to the phenyl part. This first
region was used to study H2 activation reactions at the Fe center and hydride
transfer to methenyl-H4MPT
+. The second region did not contain the substrate,
but instead the side chain of His14. This region was used for the investigation
of proton transfer from the pyridinol hydroxyl group to His14.
2 Supplementary results
2.1 Effect of the basis set
The H2 cleavage reaction in the closed conformation with the snapshot at 11 ns
was recalculated with a def2-TZVP basis set48 on all atoms. Also with the larger
basis, no stable hydride species could be located, and structure optimizations
converged to the reduced substrate. The reaction energy was −16.0 kcal/mol
compared to −18.7 kcal/mol with the smaller basis set. Hence, a larger basis
set has no significant quantitative or qualitative effect on structures; the small
effect on energies leaves conclusions and interpretation unaffected.
2.2 Potential energy surface scans
To estimate the reaction barriers for the H2 cleavage reaction with proton trans-
fer to oxypyridine (snapshot at 11 ns) and of the proton transfer from thy pyridi-
12
nol OH group to His14 in the open conformation (snapshot at 10.78 ns), we
calculated energy profiles along scan coordinates that closely resemble the reac-
tion coordinates; the profiles are plotted in Fig. 4. The scans provide an upper
bound for the reaction barrier. It was not possible to locate transition states
for the two reactions. It is likely that the flat profile of the two reactions caused
difficulties in numerical hessian calculations.
Figure 4: Plots of the potential energy surface scans. Left: Proton transfer
from pyridinol OH to His14; the scan coordinate is the difference between the
O–H and H–Nε bond lengths. Right: H2 cleavage with proton transfer to the
oxypyridine O.; the scan coordinate is the difference between the O–H and H–H
bond lengths.
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